ENOXAPARIN GINELADIUS®
ACTIVE PRINCIPLE:
Enoxaparin Sodium
INDICATION:
venous thrombosis
DATE:
23/05/2019
STATUS:
Authorized
Biosimilar medicine authorized by the AEMPS
ACTIVE PRINCIPLE:
Enoxaparin Sodium
INDICATION:
venous thrombosis
DATE:
23/05/2019
STATUS:
Authorized
Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.